Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline versus Glasser reality therapy for social anxiety disorder
IRCT20191106045356N4Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sertraline in Social Anxiety Disorder (SAD) (3 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: social anxiety score. Started May 2021; status: completed.
02
Drugs
sertraline
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on IRCT20191106045356N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191106045356N4.